Uncategorized

Semaglutide dizziness occurs in 15–20% of patients during titration due to blood pressure changes, dehydration, and blood sugar shifts—here’s what helps.

Semaglutide rarely causes heart palpitations directly, but GI distress, dehydration, and electrolyte shifts can trigger them. Here’s what patients should

Semaglutide carries a documented pancreatitis risk in 0.2–1% of patients. Learn exact symptoms, risk factors, and how to distinguish medication-induced

Semaglutide shows protective effects on kidney function in clinical trials, reducing albuminuria and slowing progression of diabetic kidney disease.

Semaglutide reduces liver fat by 30–40% in NAFLD patients through GLP-1 receptor activation and metabolic improvements—here’s what clinicians measure and

Loose skin after semaglutide occurs when rapid fat loss outpaces collagen remodeling. Learn mitigation strategies, timelines, and realistic expectations.

Semaglutide face refers to facial volume loss from rapid weight reduction. Learn what causes it, prevention strategies, and realistic management options.

Semaglutide may reduce oral contraceptive effectiveness during GI side effects. Learn interaction risks, washout periods, and safe contraception

Semaglutide requires a two-month washout before conception due to its five-day half-life and unknown fetal effects. Here’s the complete safety timeline.